Sign Out
BEZAFIBRATE is indicated for use in hyperlipedemias of Type IIa, IIb, III, IV and V.
(Fredrickson Classification) which are illustrated as follows:
Major lipid elevation of Types IIa, IIb, III, IV and V are cholesterol, cholesterol and triglycerides, cholesterol and triglycerides, triglycerides, and triglycerides (possibly cholesterol), respectively.
BEZAFIBRATE is therefore indicated for use only in patients with a fully defined and diagnosed abnormality where diet alone is insufficient to correct the condition and in whom the long-term risks associated with the condition warrant treatment.
